Award recordCONTRACT

ACCREDO HEALTH GROUP, INC

PIID 36C24219P1343· VHA· 242-NETWORK CONTRACT OFFICE 02 (36C242)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $140,265 net obligations· UEI LERPSGUE3528· TN

Description

OXERVATE EYE DROP MEDICATION. FDA APPROVAL WAS GIVEN ON AUGUST 22, 2018 TO DOMPE WHICH IS A COMPANY IN ITALY. ACCREDO HEALTH GROUP IS AN AUTHORIZED DISTRIBUTOR.

First action · last action
2019-07-01 · 2021-01-13
Transactions
2
First transaction's obligation
$188,800
Base + all options value (sum of deltas)
$140,265
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$188,800$0Base award · 2019-07-01 · this action $188,800 · running total $188,800Modification P00001 · 2021-01-13 · this action -$48,535 · running total $140,265
  • Base2019-07-01+$188,800= $188,800
  • Mod P000012021-01-13-$48,535= $140,265
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-07-01+$188,800$188,800OXERVATE EYE DROP MEDICATION. FDA APPROVAL WAS GIVEN ON AUGUST 22, 2018 TO DOMPE WHICH IS A COMPANY IN ITALY.…
Mod P00001· OTHER ADMINISTRATIVE ACTION2021-01-13−$48,535$140,265OXERVATE EYE DROP MEDICATION. FDA APPROVAL WAS GIVEN ON AUGUST 22, 2018 TO DOMPE WHICH IS A COMPANY IN ITALY.…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI LERPSGUE3528)

AwardOffice · PSC / listingNet obligationsFY
36C25226P0445252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$349,099FY2026
36C25926P0120NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$11,198FY2026
36C25925P1097NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$11,198FY2025
36C24225P1342242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$17,490FY2025
36C24225P1200242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$10,122FY2025
36C26025P0979260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$13,364FY2025

Other recipients under 6505 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24226P0942PRIORITY HEALTHCARE DISTRIBUTION INC242-NETWORK CONTRACT OFFICE 02 (36C242)$15,746FY2026
36C24226P0910THERACOM, L.L.C.242-NETWORK CONTRACT OFFICE 02 (36C242)$39,143FY2026
36C24226P0901COVERMYMEDS PHARMACY LLC242-NETWORK CONTRACT OFFICE 02 (36C242)$16,331FY2026
36C24226P0895CARDINAL HEALTH 108, LLC242-NETWORK CONTRACT OFFICE 02 (36C242)$31,219FY2026
36C24226P0900COVERMYMEDS PHARMACY LLC242-NETWORK CONTRACT OFFICE 02 (36C242)$11,315FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24219P1343_3600_-NONE-_-NONE- · retrieved 2026-09-26.